期刊文献+

冠心病合并甲状腺功能减退症冠状动脉搭桥术围术期治疗 被引量:2

The surgical treatment of coronary artery disease combined with hypothyroidism
下载PDF
导出
摘要 目的:分析总结冠心病合并甲状腺功能减退症外科治疗围术期处理方法。方法:回顾性分析20例冠心病合并甲状腺功能减退患者外科治疗围术期临床资料。结果:全组患者手术效果良好,19例患者经治疗后痊愈出院,围术期死亡1例。术前甲减确诊者均服用左旋甲状腺素片,剂量为12.5~200μg/d,平均(85±11.9)μg/d,(1.15±0.14)μg/kg,术后3d内服用剂量为25~200μg/d,平均(113±11.3)μg/d,(1.56±0.13)μg/kg;术前漏诊6例,术后确诊后立即行激素替代治疗,左旋甲状腺素片最大剂量为250μg/d,最小剂量为75μg/d,平均179.17μg/d,(2.38±0.66)μg/kg;术后机械通气时间14~146 h,平均(38±21)h,ICU停留时间16~67 h,平均(35±14.5)h;术后使用2~5μg.kg-1.min-1多巴胺改善心功能,其中使用肾上腺素维持心功能者4例,剂量在0.02~0.08μg.kg-1.min-1,行IABP辅助治疗者1例,5 d后顺利撤除。结论:冠心病合并甲状腺功能减退症外科治疗增加患者术后机械通气时间、ICU停留时间,术后恢复较甲状腺功能正常者慢,积极有效的围术期处理,术后并发症的发生率、围术期病死率并无明显增高,可安全耐受手术。 Objective: To explore perioperation treatment of coronary artery disease combined with hypothyroidism. Method: Analyze the clinical materials of CAD combined with hypothyroidism ( n = 20) that were treated with surgical procedure. The extubation time, ICU Stay time, Hospital days, Inotrope use and LOCS incidence were studied.Result:The result of surgical treatment was excellent, 19 of those were well, and one died. Extubation time was from 14 to 146 hours,(38 ± 21)hours; the ICU stay time was from 16 to 67 hours, (35 ± 14.5)hours. To imporove the cardiac function, Dopamine was administered to each patient with dose 2-5μg.kg^-1.min^-1 . Epinephrine was used in four patients with dose 0.02-0.08 μg.kg^-1.min^-1. One was supported by IABP due to the poor left ventricular function, and the IABP was moved after 5 days; one was died from MODS. Conclusion: The surgical treatment of CAD combined with hypothyroidism was safety and the result was excellent, but the extubation time, ICU Stay time and Hospital days were longer than usual. To deal with effective perioperative treatment, surgical treatment do not raise the rate of complication and mortality.
出处 《心肺血管病杂志》 CAS 2009年第4期217-219,239,共4页 Journal of Cardiovascular and Pulmonary Diseases
关键词 冠状动脉疾病 心脏外科手术 甲状腺功能减退症 Coronary artery disease Cardiac surgical procedures Hypothyroidism
  • 相关文献

参考文献8

  • 1Hirano Y, Matsumoto Y, Endoh M, et al. Off-pump coronary artery bypass grafting for unstable angina pectoris combined with hypothyroidism and chronic renal failure: report of a case. Kyobu Geka,2002,55:799-802.
  • 2Keceligil HT, Kolbakir F , Adam B, et al. Thyroid hormone aterations during and after cardiopulmonary bypass. Cardiovasc Surg, 1996,4 : 617-622.
  • 3Reinhardt W, Mocker V, Jockenhovel F, et al. Influence of coronary artery bypass surgery on thyroid hormone parameters. Horm Res, 1997,47 : 1-8.
  • 4Brogan TV, Braatton SL, Lynn AM, et al. Thyroid function in infants following cardiac surgery: comparative effects of iodinated and noniodinated topical antiseptics. Ann Thorac Surg, 1997,25 : 1583-1587.
  • 5Saatvedt K, Lindberg H, Geiran OR. Throid function during and after cardiopulmonary bypass in children. Acta Anaesthesiol Scand, 1995,42 : 1100-1103.
  • 6Bartkowski R, Wojtalik M, Korman E, et al. Thyroid hormones levels in infants during and after cardiopulmonary bypass with uhrafiltration. Eur J Cardiothorac Surg, 2002, 22:879-884.
  • 7朱洁明,陈国伟.小剂量甲状腺素在重症心力衰竭的治疗作用[J].心肺血管病杂志,2002,21(3):135-137. 被引量:6
  • 8马立萍,李雅君,宋士秋,安国营,郭海平.非体外循环下冠状动脉搭桥术后甲状腺激素水平的变化[J].心肺血管病杂志,2008,27(4):208-210. 被引量:3

二级参考文献11

共引文献7

同被引文献19

  • 1甲状腺疾病诊治指南——甲状腺功能减退症[J].中华内科杂志,2007,46(11):967-971. 被引量:358
  • 2Franklyn JA,Gammage MD,Ramsden DB,et al.Thyroid status in patients after acute myocardial infarction.Clin Sci(Lond),1984,67:585-590.
  • 3Wiersinga WM,Lie KI,Touber JL.Thyroid hormones in acute myocardial infarction.Clin Endocrinol(Oxf),1981,14:367-374.
  • 4Hamilton MA,Stevenson LW,Luu M,et al.Altered thyroid hormone metabolism in advanced heart failure.J Am Coll Cardiol,1990,16:91-95.
  • 5Utiger RD.Altered thyroid function in nonthyroidal illness and surgery.To treat or not to treat?N Engl J Med,1995,333:1562-1563.
  • 6Chopra IJ.Clinical review 86:Euthyroid sick syndrome:is it a misnomer?J Clin Endocrinol Metab,1997,82:329-334.
  • 7Thygesen K,Alpert JS,White HD.Universal definition of myocardial infarction.J Am Coll Cardiol,2007,50:2173-2195.
  • 8Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology.developed in collaboration with the heart failure association of the ESC(HFA)and endorsed by the European society of Intensive Care Medicine(ESICM).Eur Heart J,2008,29:2388-2442.
  • 9Schmidt-Ott UM,Ascheim DD.Thyroid hormone and heart failure.Curr Heart Fail Rep,2006,3:114-119.
  • 10Katzeff HL,Powell SR,Ojamaa K.Alterations in cardiac contractility and gene expression during low-T3 syndrome:prevention with T3.Am J Physiol,1997,273:E951-956.

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部